Hypoglycemia: Clinical Trials

4 trials for Hypoglycemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Terminated 4

Follow Hypoglycemia: new trials by email Literature Review of Hypoglycemia trials Research Report on Hypoglycemia

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Novel Approach for the Prevention of Hypoglycemia Associated Autonomic Failure (HAAF)
Naloxone, Diazoxide, Placebo (for Naloxone) - Diabetes Mellitus, Type 1, Hypoglycemia
Phase 4TerminatedAlbert Einstein College of Medicine42019-01-082025-09-11
Use of NPH Versus Basal Bolus Insulin for Steroid Induced Hyperglycemia
NPH Insulin, glargine, Insulin Aspart - Hyperglycemia Steroid-induced, Insulin Resistance, Diabetes
Phase 4TerminatedNorthwestern University32018-03-272020-09-11
Sitagliptin Versus Sulphonylurea in Type 2 Diabetes During Ramadan
Sitagliptin, sulphonylurea - Diabetes, Hypoglycemia
Phase 4TerminatedUniversity of Manchester222008-08-012010-01-12
Hypoglycemia Counterregulation and Symptom Perception With Insulin Detemir
Detemir - Diabetes Mellitus, Hypoglycemia
Phase 4TerminatedUniversity Hospital Tuebingen122006-03-012007-06-25

Narrower conditions

Diabetes Mellitus (4)  ·  Diabetes Mellitus, Type 1 (1)  ·  Fasting (1)  ·  Hyperglycemia (1)  ·  Insulin Resistance (1)

Broader conditions

Endocrine System Diseases (4)  ·  Glucose Metabolism Disorders (4)  ·  Metabolic Diseases (4)  ·  Nutritional and Metabolic Diseases (4)  ·  Autoimmune Diseases (1)  ·  Behavior (1)  ·  Feeding Behavior (1)  ·  Hyperinsulinism (1)  ·  Immune System Diseases (1)

Interventions

Diazoxide (1)  ·  Insulin Aspart (1)  ·  Insulin Detemir (1)  ·  Insulin Glargine (1)  ·  Insulin, Isophane (1)  ·  Isophane Insulin, Human (1)  ·  Naloxone (1)  ·  Sitagliptin Phosphate (1)  ·  Sulfonylurea Compounds (1)

Sponsors

Albert Einstein College of Medicine (1)  ·  Northwestern University (1)  ·  University Hospital Tuebingen (1)  ·  University of Manchester (1)

Countries

United States (2)  ·  Germany (1)  ·  United Kingdom (1)

Top investigators

Andreas Fritsche, MD (1)  ·  Mark Molitch, MD (1)  ·  Meredith Hawkins, MD, MS (1)  ·  Rayaz A Malik, MBChB, PhD (1)

Results publications

PMID 19885233, PMID 21387555, PMID 22784834, PMID 26474657, PMID 27995731

NIH funding

2005 (1), R01DK079974 (1)